SynCardia Facebook SynCardia Twitter SynCardia LInkedIn SynCardia Google Plus SynCardia Youtube

SynCardia Systems, Inc.

Regulatory Approvals

70cc SynCardia temporary Total Artificial Heart (TAH-t)

Bridge to Transplant Indication: For use as a bridge to donor heart transplant in cardiac transplant-eligible candidates at risk of imminent death from end-stage biventricular failure.

North America:SynCardia temporary Total Artificial Heart


HUD for Destination Therapy

The U.S. Food and Drug Administration (FDA) has approved a Humanitarian Use Device (HUD) designation for the SynCardia Total Artificial Heart to be used for destination therapy. ›› See Investigational Use Studies

50cc SynCardia Total Artificial Heart


  • CE Mark

United States:

  • Undergoing an FDA-approved Investigational Device Exemption (IDE) clinical study on effective use as a bridge to transplant in 72 patients. ›› See Investigational Use Studies

Drivers that Power the SynCardia Total Artificial Heart

Companion 2 Hospital Driver

Front view of the Companion 2 driver

  • European CE Mark: July 25, 2011
  • FDA approval: July 5, 2012
  • Health Canada: Oct. 29, 2013 
    ›› Learn more


Freedom® Portable Driver

SynCardia's Systems, Inc. Freedom® portable driver, approved by the FDA, is attached to the SynCardia Total Artificial Heart by two lines. The 13.5-pound driver provides precisely calibrated pulses of air and vacuum to the SynCardia Heart.

  • European CE Mark: March 1, 2010
  • Health Canada: May 25, 2011
  • FDA approval: June 26, 2014
    ›› Learn more

Search offcanvas